Phenotypic spectrum of GABRA1

Katrine Marie Johannesen, Carla Marini, Siona Pfeffer, Rikke S. Møller, Thomas Dorn, Christina Niturad, E. Gardella, Yvonne Weber, Marianne Søndergård, Helle Hjalgrim, Marina Nikanorova, Felicitas Becker, Line H G Larsen, Hans Atli Dahl, Oliver Maier, Davide Mei, Saskia Biskup, Karl Martin Klein, Philipp S. Reif, Felix RosenowAbdallah F. Elias, Cindy Hudson, Katherine L. Helbig, Susanne Schubert-Bast, Maria R. Scordo, Dana Craiu, Tania Djémié, Dorota Hoffman-Zacharska, H. S. Caglayan, Ingo Helbig, Jose Serratosa, Pasquale Striano, Peter De Jonghe, Sarah Weckhuysen, Arvid Suls, Kai Muru, I. Talvik, T. Talvik, H. Muhle, Ingo Borggraefe, I. Rost, Renzo Guerrini, Holger Lerche, Johannes R. Lemke, Guido Rubboli, Snezana Maljevic

Research output: Contribution to journalArticlepeer-review

Abstract

Objective: To delineate phenotypic heterogeneity, we describe the clinical features of a cohort of patients with GABRA1 gene mutations. Methods: Patients with GABRA1 mutations were ascertained through an international collaboration. Clinical, EEG, and genetic data were collected. Functional analysis of 4 selected mutations was performed using the Xenopus laevis oocyte expression system. Results: The study included 16 novel probands and 3 additional family members with a disease-causing mutation in the GABRA1 gene. The phenotypic spectrum varied from unspecified epilepsy (1), juvenile myoclonic epilepsy (2), photosensitive idiopathic generalized epilepsy (1), and generalized epilepsy with febrile seizures plus (1) to severe epileptic encephalopathies (11). In the epileptic encephalopathy group, the patients had seizures beginning between the first day of life and 15 months, with a mean of 7 months. Predominant seizure types in all patients were tonic-clonic in 9 participants (56%) and myoclonic seizures in 5 (31%). EEG showed a generalized photoparoxysmal response in 6 patients (37%). Four selected mutations studied functionally revealed a loss of function, without a clear genotype-phenotype correlation. Conclusions: GABRA1 mutations make a significant contribution to the genetic etiology of both benign and severe epilepsy syndromes. Myoclonic and tonic-clonic seizures with pathologic response to photic stimulation are common and shared features in both mild and severe phenotypes.

Original languageEnglish
Pages (from-to)1140-1151
Number of pages12
JournalNeurology
Volume87
Issue number11
DOIs
Publication statusPublished - Sep 13 2016

ASJC Scopus subject areas

  • Clinical Neurology

Fingerprint Dive into the research topics of 'Phenotypic spectrum of GABRA1'. Together they form a unique fingerprint.

Cite this